Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson׳s disease

Brain Res. 2014 Nov 17:1589:93-104. doi: 10.1016/j.brainres.2014.09.033. Epub 2014 Sep 23.

Abstract

A number of pathogenic factors have been implicated in the progression of Parkinson׳s disease (PD), including oxidative stress, mitochondrial dysfunction, inflammation, excitotoxicity, and signals mediating apoptosis cascade. 6-(methylsulfinyl)hexyl isothiocyanate (6-MSITC) is a major component in wasabi, a very popular spice in Japan and a member of the Brassica family of vegetables. This study was designed to investigate the neuroprotective effects of 6-MSITC in a PD mouse model. Mice were treated with 6-MSITC (5mg/kg twice a week) for four weeks after the unilateral intrastriatal injection of 6-hydroxydopamine (6-OHDA). On the 28th day, 6-OHDA-injected mice showed behavioral impairments, a significant decrease in tyrosine hydroxylase (TH) and an increase in apoptosis. In addition, lesioned mice showed reduced glutathione levels and glutathione-S-transferase and glutathione reductase activities. Notably, 6-MSITC demonstrated neuroprotective effects in our experimental model strongly related to the preservation of functional nigral dopaminergic neurons, which contributed to the reduction of motor dysfunction induced by 6-OHDA. Furthermore, this study provides evidence that the beneficial effects of 6-MSITC could be attributed to the decrease of apoptotic cell death and to the activation of glutathione-dependent antioxidant systems. These findings may render 6-MSITC as a promising molecule for further pharmacological studies on the investigation for disease-modifying treatment in PD.

Keywords: 6-(methylsulfinyl)hexyl isothiocyanate; 6-hydroxydopamine; Neuroprotection; Oxidative stress; Parkinson׳s disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apomorphine / pharmacology
  • Apoptosis / drug effects
  • Disease Models, Animal
  • Dopamine Agonists / pharmacology
  • Dopaminergic Neurons / drug effects
  • Dopaminergic Neurons / metabolism
  • Dopaminergic Neurons / pathology
  • Glutathione Reductase / metabolism
  • Glutathione Transferase / metabolism
  • Isothiocyanates / analysis
  • Isothiocyanates / pharmacology*
  • Isothiocyanates / therapeutic use
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Motor Activity / drug effects
  • Neostriatum / drug effects
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Oxidative Stress / drug effects
  • Oxidopamine
  • Parkinson Disease / metabolism*
  • Parkinson Disease / prevention & control
  • Rotarod Performance Test
  • Rotation
  • Substantia Nigra / drug effects*
  • Substantia Nigra / metabolism
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • Dopamine Agonists
  • Isothiocyanates
  • Neuroprotective Agents
  • Oxidopamine
  • Tyrosine 3-Monooxygenase
  • Glutathione Reductase
  • Glutathione Transferase
  • Apomorphine